PubRank

Ming-Qing Xu

Author PubWeight™ 41.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol 2013 1.02
2 Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients. World J Gastroenterol 2007 0.94
3 Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int 2010 0.91
4 Donor right hepatectomy in living donor liver transplantation: report of 143 cases. Hepatogastroenterology 2011 0.90
5 Higher tacrolimus blood concentration is related to hyperlipidemia in living donor liver transplantation recipients. Dig Dis Sci 2011 0.89
6 Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol 2012 0.89
7 Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol 2009 0.88
8 Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study. Int J Cancer 2012 0.86
9  Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol 2012 0.84
10 Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis. World J Gastroenterol 2011 0.84
11 Response of risperidone treatment may be associated with polymorphisms of HTT gene in Chinese schizophrenia patients. Neurosci Lett 2007 0.84
12 Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2011 0.84
13 Primary graft dysfunction after liver transplantation. Hepatobiliary Pancreat Dis Int 2014 0.84
14 Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection. Asian Pac J Cancer Prev 2013 0.83
15 Graft size alone should not affect donors selection and be used to predict the prognosis of recipients after living donor liver transplantation. Hepatogastroenterology 2012 0.82
16 p73 G4C14-A4T14 polymorphism and cancer risk: a meta-analysis based on 27 case-control studies. Mutagenesis 2011 0.82
17 Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT. World J Gastroenterol 2010 0.81
18 Safety of living donor liver transplantation using older donors. J Surg Res 2012 0.81
19 Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol 2012 0.80
20 Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int 2007 0.80
21 Hepatic venous outflow reconstruction in right lobe graft without middle hepatic vein. Hepatol Res 2007 0.80
22 Recurrence of hepatocellular carcinoma after liver transplantation: recurrence characteristics and risk factors. Hepatogastroenterology 2010 0.80
23 Transdiaphragmatic exposure for direct atrioatrial anastomosis in liver transplantation. Chin Med J (Engl) 2010 0.80
24 Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. World J Gastroenterol 2009 0.79
25 Hepatic venous outflow reconstruction in adult right lobe living donor liver transplantation without middle hepatic vein. Chin Med J (Engl) 2007 0.79
26 Interleukin-10-1082G/A polymorphism and acute liver graft rejection: a meta-analysis. World J Gastroenterol 2012 0.79
27 Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria. Medicine (Baltimore) 2015 0.79
28 Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: an open, randomized clinical trial of efficacy and safety. Chin Med J (Engl) 2011 0.79
29 Factors associated with early mortality after living-donor liver transplant. Exp Clin Transplant 2014 0.78
30 Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC. Hepatobiliary Pancreat Dis Int 2016 0.78
31 Causes of mortality after liver transplantation: a single center experience in mainland china. Hepatogastroenterology 2012 0.78
32 Scoring selection criteria including total tumour volume and pretransplant percentage of lymphocytes to predict recurrence of hepatocellular carcinoma after liver transplantation. PLoS One 2013 0.78
33 IFN-γ+874 A/T polymorphism and cancer risk: an updated analysis based on 32 case-control studies. Cytokine 2011 0.78
34 Prophylaxis of chronic kidney disease after liver transplantation--experience from west China. World J Gastroenterol 2012 0.78
35 Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol 2012 0.78
36 Modified techniques for adult-to-adult living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2006 0.78
37 Using a small-for-size graft might attribute to the future use of left-lobe living graft in adult to adult living donor liver transplantation. Hepatogastroenterology 2012 0.78
38 Posttraumatic stress disorder after liver transplantation. Hepatobiliary Pancreat Dis Int 2012 0.78
39 Perioperative management of primary liver cancer. World J Gastroenterol 2007 0.78
40 Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg 2014 0.78
41 Role of microRNA in liver regeneration. Hepatobiliary Pancreat Dis Int 2016 0.77
42 Differential behavioral responses of zebrafish larvae to yohimbine treatment. Psychopharmacology (Berl) 2014 0.77
43 [Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment]. Zhonghua Gan Zang Bing Za Zhi 2007 0.77
44 Is hepatectomy for huge hepatocellular carcinoma (≥ 10 cm in diameter) safe and effective? A single-center experience. Asian Pac J Cancer Prev 2014 0.77
45 Predicting protein subcellular location using digital signal processing. Acta Biochim Biophys Sin (Shanghai) 2005 0.77
46 Outcomes of adult-to-adult living donor liver transplantation: a single center experience. Chin Med J (Engl) 2009 0.77
47 Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation. Hepatobiliary Pancreat Dis Int 2006 0.77
48 Impact of graft steatosis on the post-transplantation biliary complications for living donor liver transplant recipients in China. Hepatogastroenterology 2012 0.76
49 Postoperative complications after liver transplantation with cavoportal hemitransposition. Hepatobiliary Pancreat Dis Int 2008 0.76
50 Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation. World J Gastroenterol 2009 0.76
51 Management of venous stenosis in living donor liver transplant recipients. World J Gastroenterol 2009 0.76
52 Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis. Medicine (Baltimore) 2016 0.75
53 A simple prognostic score system predicts the prognosis of solitary large hepatocellular carcinoma following hepatectomy. Medicine (Baltimore) 2016 0.75
54 Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma. Medicine (Baltimore) 2016 0.75
55 [Evaluation of the effect of living donor liver transplantation on the treatment of severe hepatitis]. Zhonghua Gan Zang Bing Za Zhi 2009 0.75
56 Zinc finger protein A20 inhibits maturation of dendritic cells resident in rat liver allograft. J Surg Res 2013 0.75
57 Management of the middle hepatic vein in right lobe living donor liver transplantation: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci 2015 0.75
58 [Using vein grafts in living donor liver transplantation]. Zhonghua Gan Zang Bing Za Zhi 2006 0.75
59 [Reconstruction of hepatic artery in adult to adult living donor liver transplantation in 104 patients]. Zhonghua Yi Xue Za Zhi 2009 0.75
60 [Prevention and treatment of biliary tract complications following adult living donor liver transplantation]. Zhonghua Yi Xue Za Zhi 2008 0.75
61 Understanding SARS with Wolfram approach. Acta Biochim Biophys Sin (Shanghai) 2004 0.75
62 [Hepatic arterial reconstruction and complications management in adult-to-adult living donor liver transplantation]. Zhonghua Wai Ke Za Zhi 2008 0.75
63 Liver transplantation for hepatic metastatic pancreatic insulinoma with a survival over five years. Chin Med J (Engl) 2012 0.75
64 Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival. Medicine (Baltimore) 2017 0.75